Introduction
The Stockholm Convention on Persistent Organic Pollutants (POPs) entered into force in 2004 and aims to protect humans and the environment from POPs (Stockholm Convention on Persistent Organic Pollutants 2009). To evaluate the effectiveness of measures taken under this Convention, time trends of POPs in human samples, mostly milk, are investigated. Today, many longterm data sets of POPs cover periods of 20-40 years; these include dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCBs), hexachlorobenzene (HCB), and polybrominated diphenyl ethers (PBDEs) (Fång et al. 2013; Glynn et al. 2012; Wilhelm et al. 2007 ).
Here we call these time-concentration trends taken from groups of individuals with similar characteristics, but sampled in different years, "cross-sectional trend data" (CSTD). Declining CSTD are often fitted with exponential functions (Craan and Haines 1998; Glynn et al. 2012; Minh et al. 2004; Norén and Meironyté 2000) . The slope of these fits provides the CSTD-based half-life, t 1/2 CSTD . Generally, depending on the time period of data collection in relation to the introduction of the ban (or voluntary phaseout) of a chemical, and the physicochemical properties of the chemical and age of the population, the time-concentration plot may be subdivided into three different periods: pre-ban (constant positive slope), transition (gradual change in slope from positive to negative), and post-ban (constant negative slope). For example, the CSTD for BDE-47 in Figure 1 increase until the mid-1990s, when the phaseout of the technical mixture of pentaBDE was implemented in Sweden (Alcock and Busby 2006) , then flattens out during the transition period, and eventually shows a negative slope during the post-ban period.
In the literature, different terms have been used to describe t 1/2 CSTD , and various interpretations of t 1/2 CSTD have been proposed (Ritter et al. 2009 ). Technically, it is straightforward to derive t 1/2 CSTD from data of the post-ban period, but there is considerable confusion about the meaning of these CSTDbased half-lives. They were interpreted to be related to either the intrinsic elimination half-life, t 1/2 elim , which indicates how fast the chemical is metabolized and excreted (elimination) from the human body (Noegrohati et al. 1992; Wolff et al. 2000) , or to the trend in exposure characterized by the half-life of decline in intake, t 1/2 in , which indicates how fast the total human exposure to the chemical is declining (e.g., time trend derived from total diet studies) Minh et al. 2004 ), or to both (Sjödin et al. 2004 ).
To resolve this confusion, Ritter et al. (2009) have provided a tool to disentangle these different half-lives. They developed a static population-based pharmacokinetic (PPK) model, called "CSTD half-life tool" (http:// www.sust-chem.ethz.ch/downloads) specifically for the post-ban period that explains the relationships between t 1/2 in , t 1/2 elim , and t 1/2 CSTD . "Static" here refers to the assumptions that there is no transfer of chemical from mother to child (i.e., in utero transfer or via breastfeeding), and that there is no change in body weight or lipid weight of any individual (Table 1, static PPK model) . Because of these assumptions, the mass-balance equation of the model can be solved analytically (Ritter et al. 2009 ). This tool first derives t 1/2 CSTD from the exponential fit of a set of CSTD, but then in addition uses the relationships among t 1/2 in , t 1/2 elim , and t 1/2 CSTD to extract also t 1/2 elim from the data, which is another important metric for the assessment of human exposure to POP-like chemicals. This is a novel approach to estimating t 1/2 elim of a persistent chemical based on human data. However, limitations of the CSTD half-life tool due to the assumptions of the static PPK model were not specifically discussed in the original publication (Ritter et al. 2009 ) and will, therefore, be presented in this commentary.
Meanwhile, dynamic PPK models that accommodate changes in individual characteristics with age and transgenerational transfer of chemicals (in utero exposure and via breastfeeding), such as the "CoZMoMAN model" or the "Ritter model," have been developed and used to evaluate POP concentrations in longitudinal (Nøst et al. 2013) or crosssectional biomonitoring data (Gyalpo et al. 2015; Ritter et al. 2011; Wong et al. 2013) . CSTD collected under the Global Monitoring Plan of the Stockholm Convention (Secretariat of the Stockholm Convention 2016) can also be evaluated with these models, which (unlike the CSTD half-life tool) can accommodate transgenerational transfer and changes in body (Table 1 , dynamic PPK model) and are not restricted to biomonitoring data from the post-ban period.
Here, our objective is to combine the knowledge gained from these previously published dynamic and static PPK models for the evaluation of CSTD. This is important because in the context of the Global Monitoring Plan of the Stockholm Convention (Secretariat of the Stockholm Convention 2016) extensive data sets have been collected and will be generated in the future, which calls for a common approach to interpreting the measured CSTD. To this end, we present five recommendations for the evaluation of CSTD sampled during the pre-ban and transition periods as observed, for example, for BDE-47 ( Figure 1 ). In addition, we explain the limitations of the CSTD half-life tool and clarify its applicability domain, which is important for future applications of this tool. Hence, our overarching goal is to illustrate which model framework can be used in which situation to fully exploit the information that is contained in CSTD.
Recommendations for the Evaluation of CSTD from Different Periods
We differentiate between two categories of POPs: a) POPs whose intrinsic elimination half-lives (t 1/2 elim ) are shorter than their intake doubling times (t 2 in ) and intake half-lives (t 1/2 in ) (e.g., BDE-47), and b) POPs whose t 1/2 elim values are longer than t 2 in and t 1/2 in (e.g., PCB-153). Thus, POPs similar to BDE-47 are referred to as "rapidly eliminated" or "short-lived" POPs, whereas POPs similar to PCB-153 are referred to as "slowly eliminated" POPs. In the following sections we illustrate with the examples of BDE-47 and PCB-153 (Figure 1 ) and other POPs how the trends in CSTD from different periods are to be interpreted based on the insights gained from the dynamic PPK model. Five recommendations for the interpretation of CSTD sets are derived in the following sections. They are listed in Table 2 .
Pre-ban Period
For newer POPs that were introduced to the market in the past 20 years, an exponential increase in CSTD is found in the population before the ban, for example, for PBDEs (Meironyté et al. 1999) . Dynamic PPK models, as developed by Ritter et al. (2011) and also used by others (Wong et al. 2013) , have shown that the doubling time of CSTD (t 2 CSTD ) directly reflects the doubling time of the intake (t 2 in ), that is, t 2 CSTD = t 2 in . Importantly, the value of t 2 CSTD = t 2 in is not affected by the intrinsic elimination half-life, t 1/2 elim . That is, if intake estimates of BDE-47 before 1995 had been reported for the Swedish population, for example from total diet studies, they would have increased with the same slope as the CSTD measured in the pre-ban period (Figure 1 ).
Sampling from breast milk is restricted to lactating women of a certain age (mostly 20-40 years). CSTD from blood samples are, however, equally valid and appropriate for elucidating time trends. For instance, the pre-ban CSTD of serum samples of 40-to 50-year-old Norwegian men provide a good estimate of the doubling time of PBDE intake by the Norwegian population (Thomsen et al. 2002) . Thus, our first recommendation is: The doubling time in intake before the phaseout of the chemical can directly be derived from the slope of the exponential increase in CSTD, that is, t 2 CSTD = t 2 in , and is completely independent of t 1/2 elim . That is, in the pre-ban period, all individuals of a population experience the same doubling time of their exposure versus calendar time. Note that the absolute intake rate (e.g., in nanograms per kilogram per day) is age-dependent.
Transition Period
In this period, calculation of a t 1/2 CSTD always results in a very long t 1/2 CSTD . For instance, t 1/2 CSTD for BDE-47 is 26.7 years for the period of 1996-2003 (Lignell et al. 2014) or 16.5 years for 1996-2006 (Lignell et al. 2009 ). In both cases t 1/2 CSTD was calculated for the first 10 years of the transition period, when concentrations are rather stable. Similarly, the CSTD of hexabromocyclododecane (HBCDD) from Swedish mothers can also be allocated to the end of the pre-ban and the beginning of the transition period (Covaci et al. 2006; Fängström et al. 2005) . Consequently, very long t 1/2 CSTD values (i.e., 15-27.7 years) were estimated for 1996 -2010 , respectively (Lignell et al. 2012 . Hence, our second recommendation is: It does not make sense to estimate t 1/2 CSTD during the transition period, even though it is technically possible. For rapidly eliminated chemicals this restriction applies only to the beginning of the transition period (see below), but for slowly eliminated chemicals the derivation of t 1/2 CSTD should be avoided for the whole transition period. The longer t 1/2 elim is, the slower is the change from increasing to decreasing CSTD during the transition period (Figure 2) . 
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However, for rapidly eliminated chemicals, it is possible to calculate a meaningful value of t 1/2 CSTD already at the end of the transition period because t 1/2 CSTD is then already equal to t 1/2 in for these chemicals. For example, after approximately 10 years into the transition period, the t 1/2 CSTD of BDE-47 reduces to 6.4 years for the period of 2004-2012 (see Table S1 for empirical CSTD and fitted t 1/2 CSTD ). Estimates for t 1/2 in from Swedish food baskets reveal a t 1/2 in value of 6.8 years for the period of 1999-2010 (Darnerud et al. 2006 ; National Food Agency 2012; Törnkvist et al. 2011) , which is very close to the 6.4 years found for t 1/2 CSTD . The reason why we find this result already around 10 years into the transition period is that, for BDE-47, t 1/2 elim < t 1/2 in : estimates of t 1/2 elim of BDE-47 are rather short, between 1.4 and 3.0 years (Geyer et al. 2004; Trudel et al. 2011) , and clearly shorter than the t 1/2 in of 6.4 years. Thus, our third recommendation is: If there are indications that t 1/2 elim < t 1/2 in , CSTD can be used to identify the half-life of decline in intake (t 1/2 CSTD = t 1/2 in ) already after 10 years into the transition period. Ritter et al. (2009) stated that if only CSTD from the post-ban period are considered, t 1/2 CSTD is equal to t 1/2 in . For chemicals like BDE-47, this is true already after around 10 years into the transition period.
If we now apply the CSTD half-life tool to derive t 1/2 elim from the CSTD of BDE-47 from the period of 2004-2012, we obtain a t 1/2 elim value of 2.2 years for BDE-47 (see Table S1 for input data used and model output), which agrees very well with estimates from previous studies-specifically, 1.4 and 3.0 years from Geyer et al. (2004) and Trudel et al. (2011) , respectively. Consequently, our fourth recommendation is: The CSTD half-life tool is applicable not only to the post-ban period but also during the transition period if the chemical fulfills the condition of t 1/2 elim < t 1/2 in , and CSTD are available for the later stage of the transition period.
The CSTD of DDT from studies of Swedish mothers Lignell et al. 2014; Norén and Meironyté 2000 ) (see Table S2 ) illustrate our fourth recommendation. Based on CSTD of DDT from the post-ban period (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) , the CSTD half-life tool estimates a t 1/2 elim of 2.2 years (Ritter et al. 2009 ). When we apply the halflife tool to CSTD from the later stage of the transition period (1980-2006, leaving out the first decade of the transition period from 1970 to 1980), we obtain a t 1/2 elim of 1.9 years (see Table S2 for input data used and model output), which is very close to the estimate of 2.2 years derived from the post-ban data.
The same will probably apply to HBCDD in the near future. Efforts to reduce HBCDD emissions to the environment were initiated around 2004 in Sweden (Remberger et al. 2004 ). Estimates of t 1/2 elim of HBCDD in humans are only a few months (Geyer et al. 2004) , which is most likely shorter than t 1/2 in of HBCDD. Therefore, as soon as HBCDD intake decreases due to reductions in emission, the CSTD half-life tool will be suitable for estimating t 1/2 elim based on future CSTD of HBCDD from the general population. Ritter et al. (2009) elim is very long, the measured CSTD violate the assumptions of the CSTD half-life tool, and estimates derived with this tool will be incorrect. For example, when CSTD for PCB-153 (see Table S3 ) are inputted into the CSTD half-life tool, the estimated t 1/2 CSTD value is 9.8 years, and the estimated t 1/2 elim is 7.0 years. This value of t 1/2 elim for PCB-153 is considerably shorter than previous estimates of 14.4-17 years (Aylward et al. 2014; Bu et al. 2015; Ritter et al. 2011) , and thus appears to be incorrect. Additionally, PCB-153 concentrations during the post-ban period (25-30 years after the highest concentrations had occurred, i.e., since around 1995) have been reported to increase with age within cross-sectional populations (Quinn and Wania 2012; Ritter et al. 2011) , which is possible only if t 1/2 elim > t 1/2 in (Ritter et al. 2011) . Therefore, our fifth recommendation is: If there are indications that t 1/2 elim > t 1/2 in or long t 1/2 elim values in general (roughly ≥ 10 years), the CSTD half-life tool should not be applied.
Post-ban Period
The reason why the CSTD half-life tool is not applicable to PCB-153 and other chemicals with long t 1/2 elim is that, due to the long t 1/2 elim of the chemical, the body burden later Table 2 . Recommendations for evaluation of CSTD.
Recommendations
Relevant time period
1. The doubling time in intake before the phaseout of the chemical can directly be derived from the slope of the exponential increase in CSTD, i.e., t 2 CSTD = t 2 in , and is completely independent of t 1/2 elim .
Pre-ban period 2. It does not make sense to estimate a t 1/2 CSTD during the transition period, even though it is technically possible.
Transition period 3. If there are indications that t 1/2 elim < t 1/2 in , CSTD can be used to identify the half-life of decline in intake (t 1/2 CSTD = t 1/2 in ) already after 10 years into the transition period. volume 124 | number 7 | July 2016 • Environmental Health Perspectives in life is still influenced by the exposure to the chemical much earlier in life (i.e., from in utero exposure and transfer via breastfeeding). This fact is not considered in the assumptions made in the CSTD half-life tool (Table 1, static PPK model) . A more realistic model is a dynamic PPK model. Such a model is not restricted to the post-ban period but includes the pre-ban and transition periods, and longitudinal POP concentrations are estimated for each individual, including transgenerational transfer of chemical from mother to child (Table 1, dynamic PPK model) . Figure 2 compares modeled CSTD with the assumptions of the CSTD half-life tool (A) and under more realistic assumptions (B) for two hypothetical chemicals. Importantly, as illustrated in Figure 2B , for chemicals whose t 1/2 elim exceeds t 1/2 in (circles), the slope in CSTD is not equal to the slope in intake of the chemical at any time in the post-ban period: that is t 1/2 CSTD ≠ t 1/2 in . In contrast, for chemicals with t 1/2 elim ≤ t 1/2 in , t 1/2 CSTD = t 1/2 in is true (diamonds). This shift in the slope for slowly eliminated chemicals in Figure 2B (red line) is due to the non-zero initial concentration at birth and intake via breastfeeding. The effect of transgenerational input is pronounced in the post-ban period, when intake is declining and therefore the contribution from a "contaminated" mother is important.
Another case that illustrates the limitations of the CSTD half-life tool is HCB. Two studies have reported a t 1/2 elim of HCB of around 6 years (Bu et al. 2015; To-Figueras et al. 2000) , and the t 1/2 in is 12.0 years for the period of 1975-2010 in Sweden (Darnerud et al. 2006; National Food Agency 2012; Törnkvist et al. 2011; Vaz 1995) . When the CSTD and the intake data from Table S4 are inputted, the CSTD half-life tool estimates a t 1/2 CSTD value of 14.9 years, and a t 1/2 elim value of only 2.4 years, which is considerably shorter than previous t 1/2 elim estimates of approximately 6 years (Bu et al. 2015; To-Figueras et al. 2000) . As for PCB-153, cross-sectional age-concentration trends should be evaluated to confirm the model outputs of the CSTD half-life tool. However, this cross-check can be performed only with cross-sectional data from the post-ban period, because age-concentration trends will not differ between slowly and rapidly eliminated POPs during the pre-ban and transition periods (Gyalpo et al. 2015; Quinn and Wania 2012) . If t 1/2 elim is substantially shorter than t 1/2 in , as suggested by the CSTD half-life tool estimates for HCB, HCB concentrations should not increase with age in cross-sectional populations. However, cross-sectional biomonitoring data from Australia (Bu et al. 2015) , Spain (Zubero et al. 2015) , and Germany (Becker et al. 2002) do show increasing HCB concentration with increasing age, indicating that t 1/2 elim is underestimated by the CSTD half-life tool. Hence, it is advisable not to use this tool for evaluating CSTD of HCB.
Conclusions
In evaluating decreasing CSTD, it is important to distinguish between three half-lives: the CSTD-based half-life (t 1/2 CSTD ), the half-life of decline in intake (t 1/2 in ), and the intrinsic elimination half-life (t 1/2 elim ). During the pre-ban period, the doubling time of CSTD (t 2 CSTD ) is equal to the doubling time of intake (t 2 in ); during the transition period, calculation of t 1/2 CSTD yields nonsensical results; and in the post-ban period, t 1/2 CSTD is equal to t 1/2 in only for chemicals that are rapidly eliminated, whereas for slowly eliminated chemicals, t 1/2 CSTD only represents the upper limit of t 1/2 in . Importantly, t 1/2 CSTD never equals t 1/2 elim . For chemicals for which estimates of short t 1/2 elim exist (e.g., extrapolated from animal studies or derived from highly exposed individuals), the CSTD half-life tool will provide a good estimate of t 1/2 elim based on CSTD from the later stage of the transition period. In contrast, for chemicals that may have long t 1/2 elim values, t 1/2 elim can be derived only with dynamic PPK models combined with sequential sets of cross-sectional data. This approach requires long-term planning since cross-sectional data sets are needed from at least 20 years after the ban of the chemical.
As pointed out by Ritter et al. (2009) , the t 1/2 CSTD is specific to the sampled population. Different countries can have different t 1/2 CSTD values for the same chemicals because t 1/2 CSTD is a measure of the degree of the reduction in exposure to a chemical, which is governed by the country's amount in production and use and the time of a phaseout. It is an "apparent" property that is specific to the environmental conditions in the country and therefore not something that has to be globally identical.
